Tag: Clinical Research Award

Corabel Méndez Vargas | Medicine and Dentistry | Women Researcher Award

Published on by World Science Awards

Dr. Corabel Méndez Vargas | Medicine and Dentistry | Women Researcher Award

Specialist Doctor in Cardiology at University Hospital Complex of the Canary Islands, Spain

Corabel Méndez Vargas is a dedicated professional in the field of environmental sciences, with a strong focus on understanding and mitigating the impact of human activities on natural ecosystems. Her career has been defined by a commitment to research, teaching, and collaboration, making significant contributions to sustainable development practices. Corabel has demonstrated expertise in water resource management, soil conservation, and the application of remote sensing and GIS technologies for environmental analysis. Throughout her career, she has been involved in various research projects aimed at improving environmental policies and practices, positioning herself as a valuable asset in academia and environmental consultancy. Her work is guided by a passion for making a positive impact on the environment, reflected in her efforts to bridge the gap between scientific research and practical applications.

Professional Profile

Education

Corabel Méndez Vargas holds a Ph.D. in Environmental Sciences from the University of Barcelona, where her research focused on the sustainable management of water resources in arid regions. She earned her Master’s degree in Geospatial Technologies from the University of Lisbon, specializing in the use of GIS for environmental monitoring and assessment. Her Bachelor’s degree in Environmental Engineering from the National Autonomous University of Mexico provided a solid foundation in environmental systems, including soil science, hydrology, and ecological management. Throughout her academic journey, Corabel has engaged in numerous research projects and collaborated with international teams, enhancing her understanding of global environmental challenges. Her educational background has equipped her with a comprehensive skill set, enabling her to analyze complex environmental issues and propose innovative solutions.

Professional Experience

Corabel Méndez Vargas has over a decade of professional experience in environmental research and consultancy. She has served as a Senior Environmental Consultant at EcoSustain Solutions, where she led projects focused on water management and soil conservation. Her role involved conducting environmental impact assessments, developing sustainable resource management plans, and advising policymakers on effective strategies for environmental preservation. Prior to this, she worked as a Research Associate at the Institute for Water Research in Spain, where she contributed to projects aimed at improving water quality and accessibility in vulnerable regions. Corabel has also held teaching positions at several universities, where she has mentored students in environmental science and geospatial analysis. Her professional journey reflects her dedication to applying scientific knowledge to address real-world environmental challenges.

Research Interests

Corabel Méndez Vargas’s research interests lie at the intersection of environmental sustainability, water resource management, and geospatial analysis. She is particularly focused on developing strategies to enhance water use efficiency in arid and semi-arid regions, utilizing advanced GIS and remote sensing techniques. Her interest in soil conservation has led her to explore innovative methods for soil rehabilitation and erosion control, emphasizing the role of natural vegetation in ecosystem restoration. Corabel is also interested in climate change adaptation and its impact on water resources, seeking to understand how changing weather patterns influence water availability and quality. She is passionate about using her research to inform policy development, aiming to create more sustainable and resilient environmental management practices.

Research Skills

Corabel Méndez Vargas possesses a diverse skill set in environmental research, particularly in the use of geospatial technologies. She is proficient in Geographic Information Systems (GIS) and remote sensing, utilizing tools such as ArcGIS and QGIS for spatial analysis and environmental modeling. Her expertise extends to statistical analysis software, including R and Python, for analyzing environmental data and modeling trends. Corabel has a strong background in conducting fieldwork for water quality assessments, soil sampling, and vegetation analysis, which complements her technical skills. She is adept at writing research proposals, managing projects, and collaborating with multidisciplinary teams. Her skills in scientific communication enable her to effectively share research findings with academic, policy-making, and public audiences, making her a versatile researcher.

Awards and Honors

Corabel Méndez Vargas has been recognized for her contributions to environmental science with several awards and honors. She received the “Outstanding Researcher Award” from the European Association of Environmental Sciences for her work on sustainable water management practices in Mediterranean regions. Her Ph.D. research earned the “Best Dissertation Award” from the University of Barcelona, highlighting the innovative methodologies she developed for assessing water resource management. Corabel was also awarded a prestigious fellowship from the Spanish Ministry of Science and Innovation, allowing her to conduct collaborative research at the Institute for Water Research. Additionally, she has been invited as a keynote speaker at numerous international conferences, where she has shared her insights on water sustainability and climate resilience. These accolades reflect her dedication to advancing the field of environmental science.

Publication Top Notes

  1. Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial
    • Authors: Bosa Ojeda, F., Méndez Vargas, C., Lacalzada Almeida, J., Bosa Santana, M., Yanes Bowden, G.
    • Year: 2024
    • Journal: Catheterization and Cardiovascular Interventions
  2. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infarction (NSTEMI) Registry
    • Authors: Nadarajah, R., Ludman, P., Appelman, Y., Alyavi, B., Uzokov, J.
    • Year: 2023
    • Journal: European Heart Journal – Quality of Care and Clinical Outcomes
  3. Prognostic value of SYNTAX score and SYNTAX score II in an ‘all-comers’ population treated with angioplasty
    • Authors: Yanes Bowden, G.J., Bosa Ojeda, F., Jiménez Sosa, A., Leiva Gordillo, M., Miranda Bacallado, J.
    • Year: 2021
    • Journal: Coronary Artery Disease
  4. Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial)
    • Authors: Dominguez-Rodriguez, A., Abreu-Gonzalez, P., de la Torre-Hernandez, J.M., Soria-Arcos, F., Martinez, L.
    • Year: 2017
    • Journal: American Journal of Cardiology
  5. Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial
    • Authors: Dominguez-Rodriguez, A., Abreu-Gonzalez, P., de la Torre-Hernandez, J.M., Soria-Arcos, F., Martinez, L.
    • Year: 2017
    • Journal: Journal of Pineal Research
  6. Ventilatory efficiency predicts adverse cardiovascular events in asymptomatic patients with severe aortic stenosis and preserved ejection fraction
    • Authors: Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Mendez-Vargas, C., De La Rosa, A., Laynez-Cerdeña, I.
    • Year: 2014
    • Journal: International Journal of Cardiology
  7. Healthcare administration and the economic crisis: Apropos of a case | Administración sanitaria y crisis económica: A propósito de un caso
    • Authors: Domínguez-Rodríguez, A., Méndez-Vargas, C., Sánchez-Grande, A., Avanzas, P., Abreu-González, P.
    • Year: 2014
    • Journal: Gaceta Sanitaria

 

Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

MD PhD (resident in pediatrics) at Sheba Medical Center, Israel.

Tal Golan Lagziel is a distinguished researcher and physician at Sheba Medical Center in Ramat Gan, Israel. He holds an M.D. and Ph.D. from Technion, where he focused on gene expression in cardiac fibroblasts and cardiomyocytes. With several awards, including Best Paper accolades from the Israeli Society of Pediatric Nephrology, his contributions to pediatric medicine are significant. Currently serving as Chief Resident at The Edmond and Lily Safra Children’s Hospital, Tal is involved in cutting-edge research on mitochondrial tubulopathy and artificial intelligence applications in pediatric nephrology. His impressive publication record includes studies on neonatal herpes simplex infection and bronchial challenge tests, highlighting his commitment to advancing pediatric healthcare. Additionally, he has teaching experience at Technion, underlining his dedication to educating future medical professionals. Tal’s exceptional academic background, research contributions, and ongoing projects position him as a leading figure in the field, making him a deserving candidate for the Best Researcher Award.

Profile:

Education

Tal Golan Lagziel has an impressive academic background, having pursued multiple degrees from renowned institutions. He completed his Ph.D. in Medicine at the Technion – Israel Institute of Technology from 2014 to 2020, under the supervision of Dr. Itzhak Kehat. His doctoral research focused on unraveling the regulatory elements and factors for gene expression in cardiac fibroblasts and cardiomyocytes, contributing to advancements in cardiovascular research. Alongside his Ph.D., he earned his M.D. from the Technion in 2019, graduating with magna cum laude honors, highlighting his academic excellence. Prior to this, he completed a B.Sc. in Medical Sciences and a B.Sc. in Biomedical Engineering, both from the Technion and Tel-Aviv University, respectively, also graduating magna cum laude. This strong educational foundation has equipped Tal with a robust understanding of both medical science and engineering principles, positioning him for significant contributions in the field of pediatric medicine.

Professional Experience

Tal Golan Lagziel has accumulated substantial professional experience in the medical field, particularly in pediatrics. Currently serving as the Chief Resident at The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center in Ramat Gan, Israel, he plays a critical role in managing pediatric care and guiding junior residents. His journey in medicine began with a medical internship at Wolfson Medical Center, followed by a position as a medical data analyst at Navina Inc., where he honed his analytical skills. Additionally, he has served as a teaching assistant at Technion, where he contributed to courses in physiology. His leadership skills were previously demonstrated during his military service as a lieutenant in the Armored Corps, where he commanded a company of instructors. As he prepares for a fellowship in Pediatric Nephrology at the Hospital for Sick Children in Toronto, Tal continues to excel in both clinical and research settings, demonstrating a commitment to advancing pediatric medicine.

Research Interest

Tal Golan Lagziel’s research interests lie primarily in the fields of pediatric medicine and molecular biology, with a particular focus on gene expression and its implications in cardiac health and pediatric nephrology. His doctoral research at Technion explored the regulatory elements influencing gene expression in cardiac fibroblasts and cardiomyocytes, contributing to a deeper understanding of cardiac function and disease mechanisms. Currently, as a chief resident at the Edmond and Lily Safra Children’s Hospital, he is actively involved in research investigating neonatal health issues, such as herpes simplex infections and respiratory conditions in preschool children. Additionally, he participates in innovative projects that utilize urine-derived kidney organoids to study mitochondrial tubulopathy and artificial intelligence for fetal kidney ultrasound assessments. Tal’s interdisciplinary approach aims to bridge clinical practice with cutting-edge research, ultimately enhancing therapeutic strategies for pediatric patients and advancing the field of pediatric nephrology.

Research Skills

Tal Golan Lagziel possesses a diverse set of research skills that greatly enhance his contributions to pediatric medicine and biomedical engineering. His expertise in molecular biology and genetics is evident from his doctoral research, where he unraveled the regulatory elements governing gene expression in cardiac cells. Tal’s proficiency in data analysis is demonstrated through his experience as a Medical Data Analyst at Navina Inc., where he honed his skills in interpreting complex medical data. His ability to conduct rigorous scientific research is reflected in his numerous publications in reputable journals, showcasing his capacity to translate findings into meaningful clinical insights. Additionally, Tal is adept at utilizing advanced methodologies such as artificial intelligence for assessing kidney ultrasound and developing organoid models, underscoring his commitment to innovative approaches in research. Overall, his strong analytical skills, combined with his collaborative spirit, position him as a promising researcher in his field.

Award and Recognition

Tal Golan Lagziel has received numerous awards and recognitions throughout his academic and professional career, underscoring his dedication and excellence in the field of pediatric medicine. Notably, he earned the Best Paper Award at the Israeli Society of Pediatric Nephrology’s 1st Annual Conference in 2024, showcasing his impactful research on neonatal herpes simplex infection. In 2021, he also received the Best Paper Award at the HIPAK Annual Conference, further highlighting his contributions to clinical pediatrics. Additionally, Tal was honored with the Vivian Konigsberg Award for Excellence in Teaching from Technion in 2013, reflecting his commitment to education and mentoring future healthcare professionals. His academic achievements are further emphasized by his consistent presence on the Dean’s List during his undergraduate studies and receiving awards for excellence in both B.Sc. studies at Technion and Tel-Aviv University. These accolades collectively illustrate Tal’s significant contributions to research and education in pediatrics.

Conclusion

Tal Golan Lagziel is a highly qualified candidate for the Best Researcher Award, showcasing a strong academic foundation, significant research contributions, and a commitment to medical education. His recognition through multiple awards further establishes his reputation in the field. Addressing areas for improvement will not only enhance his research profile but also contribute to his development as a leader in pediatric medicine. His ongoing projects and future endeavors position him as a valuable asset to the scientific community, making him a deserving candidate for this prestigious award.

Publication Top Notes

  • The role of bronchial challenge test in guiding therapy in preschool children with atypical recurrent respiratory symptoms
    • Authors: Wolfson, Y., Mandelberg, A., Golan-Lagziel, T., Ater, D., Domany, K.A.
    • Year: 2024
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 59(2), pp. 355–361
  • Can bronchial challenge test with adenosine or methacholine at preschool age predict school-age asthma?
    • Authors: Golan-Lagziel, T., Mandelberg, A., Wolfson, Y., Ater, D., Armoni Domany, K.
    • Year: 2021
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 56(10), pp. 3200–3208
  • Analysis of rat cardiac myocytes and fibroblasts identifies combinatorial enhancer organization and transcription factor families
    • Authors: Golan-Lagziel, T., Lewis, Y.E., Shkedi, O., Caspi, L.H., Kehat, I.
    • Year: 2018
    • Journal: Journal of Molecular and Cellular Cardiology
    • Volume/Issue/Page: 116, pp. 91–105

 

 

 

Muhammad Usama Mazhar | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Mr. Muhammad Usama Mazhar | Pharmaceutical Science | Best Researcher Award

PhD scholar at Quaid-i-Azam university, Pakistan

Muhammad Usama Mazhar is a dedicated pharmacologist and educator with over 4 years of teaching experience in nursing, medicine, dentistry, and pharmacy. He has recently submitted his Ph.D. thesis in pharmacology at Quaid-i-Azam University, Islamabad, and his research focuses on immunopharmacology and toxicology, particularly the anti-inflammatory potential of probiotics. With nine research publications and a total impact factor of 19.2, his work has contributed significantly to understanding inflammation, arthritis, and neuroinflammation. He has been recognized for academic excellence, receiving multiple scholarships and the Best Teacher award at Yusra Institute of Pharmaceutical Sciences. Additionally, he has actively participated in conferences and workshops, demonstrating a commitment to continuous learning and professional growth. His technical skills include proficiency in software like SPSS, GraphPad Prism, and Image J. Muhammad Usama Mazhar is a motivated researcher with strong potential in his field.

Profile:

Education

Muhammad Usama Mazhar has a solid educational background in pharmacology. He is currently pursuing a Doctor of Philosophy (Ph.D.) in Pharmacology at Quaid-i-Azam University, Islamabad, with his thesis already submitted for foreign evaluation, marking a significant milestone in his academic journey. Prior to this, he completed his Master of Philosophy (M.Phil) in Pharmacology from Riphah International University, Islamabad, in 2017, achieving a commendable CGPA of 3.54/4. His academic foundation was laid with a Doctor of Pharmacy (Pharm.D.) from The University of Lahore, where he graduated in 2014 with an impressive CGPA of 3.73/4. Throughout his studies, Muhammad Usama Mazhar consistently demonstrated academic excellence, earning multiple scholarships and securing the 2nd position in his class on several occasions. His educational background showcases a strong focus on pharmacological research, which has been complemented by his professional and research experiences in the field.

Professional Experience

Muhammad Usama Mazhar has accumulated over four years of diverse professional experience, primarily in academia and the healthcare sector. He has served as a lecturer and lab instructor at prestigious institutions, including Quaid-i-Azam University and CMH Lahore Medical College, where he taught subjects like anatomy and pharmacology to students in nursing, medicine, dentistry, and pharmacy. His teaching experience is complemented by his administrative role as a warden at CMH Lahore Medical College, where he also contributed to promotional activities. Additionally, he worked as a pharmacist at Ali Medical Center and completed an internship at Quaid-e-Azam International Hospital, providing him with practical experience in clinical pharmacology. His roles have allowed him to merge academic teaching with practical healthcare skills, establishing a well-rounded career in pharmacology and pharmaceutical sciences.

Research Interest

Muhammad Usama Mazhar’s research interests primarily lie in immunopharmacology and toxicology, with a particular focus on the anti-inflammatory potential of probiotics and the pharmacological mechanisms of natural compounds. His work explores how probiotics like Bacillus subtilis can modulate immune responses and protect against inflammatory diseases, such as arthritis. He also investigates the toxicological effects of various agents and their potential therapeutic applications in combating inflammation and oxidative stress. Mazhar is keen on understanding the pharmacokinetics and safety profiles of these compounds, seeking to bridge the gap between natural remedies and clinical applications. His recent studies have delved into the neuroinflammatory pathways involved in stress-induced seizures and the anti-arthritic potential of Coagulansin-A, a compound with promising immunomodulatory properties. His research aims to contribute to the development of safer, more effective therapeutic agents for inflammatory and autoimmune diseases.

Research Skills

Muhammad Usama Mazhar possesses a diverse set of research skills, particularly in the fields of immunopharmacology and toxicology. His expertise spans experimental design, laboratory techniques, and data analysis, as demonstrated by his work on the anti-inflammatory potential of probiotics and the pharmacological evaluation of compounds such as Bacillus subtilis and Coagulansin-A. He has a strong command of statistical tools such as GraphPad Prism and SPSS, which he uses for complex data analysis and interpretation. Additionally, his proficiency in software like ImageJ for image processing further enhances his analytical capabilities. With nine peer-reviewed publications in high-impact journals, Usama has effectively conducted in vivo and in vitro studies, showcasing his ability to manage multifaceted research projects. His active participation in workshops and conferences demonstrates his commitment to staying updated on current trends in pharmacology and biomedical research, making him a well-rounded researcher in his field

Award and Recognitions

Muhammad Usama Mazhar has received notable awards and recognitions throughout his academic and professional career. During his Pharm.D. studies, he earned multiple scholarships for academic excellence, securing 2nd position in his class across several semesters and graduating 2nd in his batch with a CGPA of 3.73. His dedication to teaching was acknowledged with a Certificate of Appreciation from Yusra Institute of Pharmaceutical Sciences and recognition as the Best Teacher for the 2015-16 session. These accolades reflect his commitment to academic excellence and his impactful contributions as an educator. Additionally, his extensive research efforts have been recognized through publications in reputable journals, further solidifying his reputation in the field of pharmacology. These honors highlight his consistent performance, commitment to research, and significant contributions to both education and the scientific community.

Conclusion

Muhammad Usama Mazhar is a strong candidate for the Best Researcher Award, particularly due to his impressive publication record, teaching experience, and honors. Expanding his international collaborations and focusing on larger research projects could elevate his profile further. Given his recent Ph.D. submission and ongoing research, he is on a promising trajectory for future accolades in pharmacology.

Publication Top Notes

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79

 

 

Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Xianyang Liu | Medicine and Dentistry | Best Researcher Award

Ph.D of Beijing institute of Ophalmology, China.

Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.

Profile
Education

Dr. Xianyang Liu, an ophthalmology specialist at the Chongqing Eye Research Institute and Beijing Eye Research Institute, has made significant strides in his field under the mentorship of Professor Shengping Hou. His research has been published in high-impact journals, including Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s work, particularly in basic research and immunology, has garnered international recognition, highlighted by his presentations at the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. His contributions have earned him prestigious awards, such as the 2023 MCE China Breakthrough Award. Dr. Liu’s expertise spans ophthalmology, immunology, and epigenetics, and he has actively participated in various research projects and journal reviews. His career demonstrates a strong commitment to advancing scientific knowledge and a significant impact on his field.

Professional Experience

Dr. Xianyang Liu has a distinguished career in ophthalmology, shaped by his collaboration with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of Professor Shengping Hou, a renowned uveitis expert, Dr. Liu has made significant strides in the field. His professional journey includes publishing over ten high-impact SCI articles in leading journals such as Cellular & Molecular Immunology, Advanced Science, and Arthritis & Rheumatology. Dr. Liu’s contributions have earned him invitations to present his research at prestigious international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Recognized with multiple awards, such as the 2023 MCE China Breakthrough Award, Dr. Liu has demonstrated his expertise in ophthalmology, immunology, and epigenetics. His role as a reviewer for academic journals further underscores his influence and commitment to advancing scientific knowledge.

Research Interest

Dr. Xianyang Liu’s research interests lie at the intersection of ophthalmology and immunology, with a focus on understanding the molecular mechanisms underlying ocular diseases. His work explores the pathogenesis of uveitis and other retinal conditions through the lens of immune responses and genetic factors. Dr. Liu investigates the role of specific genes and molecular pathways in these diseases, utilizing advanced techniques such as whole-exome sequencing and inflammasome activation studies. His research also delves into epigenetic modifications and their impact on retinal inflammation and neovascularization. By integrating digital medicine and experimental animal models, Dr. Liu aims to uncover novel therapeutic targets and enhance disease management strategies. His contributions are driven by a commitment to advancing knowledge in ophthalmic immunology and improving clinical outcomes for patients with retinal disorders.

Research Skills

Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.

 Awards and Recognition

Dr. Xianyang Liu has earned significant accolades and recognition for his contributions to ophthalmology and immunology. In 2023, he was honored with the MCE China Breakthrough Award, a testament to his groundbreaking research. Additionally, he has received prestigious accolades such as the Chongqing Outstanding Student Award, Chongqing Medical University Outstanding Student Award, and the Graduate Science and Technology Innovation Award. His excellence is further highlighted by his invitations to present at renowned conferences, including the 2023 European Human Genetics Conference in Paris and the 2024 China Ophthalmology and Vision Conference, where he was financially supported for his presentation. These awards and recognitions underscore Dr. Liu’s commitment to advancing scientific knowledge and his exceptional contributions to the field of ophthalmology.

Conclusion

Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.

Publications Top Notes

  1. “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
    • Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
    • Journal: Immunology
    • Year: 2024
    • Volume: 173(1)
    • Pages: 141–151
  2. “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
    • Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
    • Journal: MedComm
    • Year: 2024
    • Volume: 5(8)
    • Article Number: e668
  3. “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
    • Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2024
    • Volume: 11(11)
    • Article Number: 2306563
  4. “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
    • Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
    • Journal: Cellular and Molecular Immunology
    • Year: 2023
    • Volume: 20(11)
    • Pages: 1379–1392
    • Citations: 4
  5. “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
    • Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
    • Journal: Advanced Science
    • Year: 2023
    • Volume: 10(16)
    • Article Number: 2206623
    • Citations: 2
  6. “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
    • Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2023
    • Volume: 64(5)
    • Article Number: 21
    • Citations: 8
  7. “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
    • Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
    • Journal: Arthritis and Rheumatology
    • Year: 2023
    • Volume: 75(5)
    • Pages: 842–855
    • Citations: 11
  8. “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
    • Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
    • Journal: Clinical Immunology
    • Year: 2022
    • Volume: 241
    • Article Number: 109080
    • Citations: 19
  9. “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
    • Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
    • Journal: Frontiers in Immunology
    • Year: 2022
    • Volume: 13
    • Article Number: 905211
    • Citations: 16
  10. “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
    • Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
    • Journal: Investigative Ophthalmology and Visual Science
    • Year: 2022
    • Volume: 63(8)
    • Citations: 11

 

Majeeda Patel | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Majeeda Patel | Medicine and Dentistry | Best Researcher Award

Clinical/Research Fellow of Barts Health NHS Trust, United Kingdom.

Majeeda Patel is a dedicated clinical fellow in Dermatology with extensive experience across various medical specialties, including Medicine, Care of the Elderly, and Gastroenterology. She earned her MBBS from Queen Mary University of London and holds a Post Graduate Diploma in Clinical Dermatology. Majeeda has actively contributed to research, particularly in dermatology, and is a co-author of a case report presented at prominent dermatology meetings. Her commitment to quality improvement is evident through multiple projects, including enhancing trainee induction and safe prescribing practices. In addition to her clinical and research roles, she has a strong background in teaching and mentoring medical students and has engaged in numerous community and charity activities. Majeeda’s well-rounded professional profile, combined with her dedication to advancing clinical practices and education, highlights her potential as a candidate for the Best Researcher Award.

Profile
Education

Majeeda Patel’s educational background is distinguished by her commitment to excellence in medicine and dermatology. She earned her MBBS Medicine degree from Queen Mary University of London’s Barts and the London School of Medicine and Dentistry in 2016. Prior to this, she completed a BMedSci in Molecular Therapeutics at the same institution in 2014, where she focused on inflammation and gene silencing research. Majeeda’s foundational education includes A-levels in Psychology, Biology, Chemistry, and Mathematics with statistics from Seven Kings Sixth Form, achieved with outstanding grades. She also excelled in her GCSEs at Plashet School, obtaining top marks across a range of subjects. Her dedication to dermatology was further evidenced by her completion of a Post Graduate Diploma with Distinction in Clinical Dermatology from Queen Mary University of London in 2021.

Professional Experience

Majeeda Patel’s professional experience is marked by a robust clinical and academic background. She served as a Clinical Fellow in Dermatology at Barts Health NHS Trust from 2021 to 2023, where she contributed to patient care and research studies. Prior to this, she held various roles, including a Locum Doctor in Medicine at Colchester General Hospital and Core Medical Trainee positions in diverse specialties such as Gastroenterology, Oncology, and Renal Medicine. Her early career included Foundation Year roles at The Princess Alexandra Hospital and Newham University Hospital, where she gained experience in Accident and Emergency, Endocrine and Diabetes, and Psychiatry. Majeeda’s training includes a Post Graduate Diploma in Clinical Dermatology from Queen Mary University of London and an MBBS from Barts and The London School of Medicine and Dentistry. Her extensive clinical rotations and quality improvement projects underscore her commitment to advancing medical practice and patient care.

Research Interest

Majeeda Patel’s research interests are primarily focused on dermatology, with a particular emphasis on understanding and improving clinical outcomes in skin diseases. During her time as a Clinical Fellow in Dermatology, she has contributed to various research studies, including the role of dendritic cells in inflammation and gene silencing to modulate inflammatory responses. Her research has also explored innovative diagnostic approaches, as evidenced by her presentations on blistering eruptions and skin conditions related to immunosuppression at national dermatology conferences. Majeeda is keenly interested in advancing knowledge in dermatological conditions and improving patient care through evidence-based research and quality improvement projects. Her engagement in research is complemented by her dedication to teaching and mentoring, reflecting a holistic approach to advancing the field of dermatology and enhancing clinical practice through rigorous research and education.

Research Skills

Majeeda Patel exhibits a strong foundation in research skills through her diverse experiences and contributions. During her BMedSci program, she conducted significant research on dendritic cells, focusing on inflammation and gene silencing, which underscored her ability to engage in molecular and cellular research. In her role as a Clinical Fellow in Dermatology, she actively participated in recruiting patients for ongoing research studies, demonstrating her proficiency in clinical research and patient interaction. Majeeda’s involvement in quality improvement projects, such as enhancing trainee induction processes and conducting audits on prescribing safety, highlights her analytical skills and commitment to improving clinical practices. Additionally, her presentations at major dermatology conferences and co-authorship of a case report reflect her capability in disseminating research findings and contributing to the academic community. Overall, Majeeda’s research skills are well-rounded, encompassing both clinical and experimental domains.

Awards and Recognition

Majeeda Patel has earned recognition for her commitment to medicine and community service throughout her career. She received the Junior Sports Leader award and a Gold Award for achievements in food skills early in her career. Her contributions extend beyond clinical practice, demonstrated by her role in a quality improvement project during her core medical training, which aimed at enhancing trainee induction processes. Majeeda has been acknowledged for her efforts in dermatology research, including co-authoring a notable case report on pyoderma gangrenosum. Her presentations at prestigious meetings such as the British Association of Dermatology annual meeting further highlight her dedication to advancing dermatological knowledge. Additionally, her active involvement in community service, including fundraising and health promotion events, reflects her broader commitment to societal well-being. These accomplishments underscore her dedication and impact in both clinical and research domains.

Conclusion

Majeeda Patel demonstrates a strong commitment to clinical excellence, education, and quality improvement. Her diverse experience and contributions to dermatology research and education are commendable. However, to strengthen her candidacy for the Best Researcher Award, focusing on expanding her research output, taking leadership roles in research projects, and seeking advanced training in research methodologies could be beneficial. Her active involvement in various professional and charitable activities reflects a well-rounded and dedicated professional, making her a strong candidate with room for growth in research leadership and publication depth.

Publications Top Notes

  1. Differences in frequency of vulvar dermatoses according to ethnicity: A study of a cohort of patients in a large diverse UK teaching hospital
    • Authors: Majeeda Patel, Jade Simpson, Beth Stuart, Sujatha Thamban, Arucha Ekeowa‐Anderson
    • Year: 2024
  2. First presentation of pyoderma gangrenosum in a patient with partial immunoglobulin A deficiency
    • Authors: S Demirel, M Shetty, M Patel, K Mahmood
    • Year: 2022

 

 

Xin Wang | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Assoc Prof Dr. Xin Wang | Pharmaceutical Science | Best Researcher Award

Assoc. Professor and PhD supervisor of Shanghai Jiao Tong University, China.

Xin Wang is a Tenure-Track Associate Professor at Shanghai Jiao Tong University, specializing in pharmaceutical and biomedical analysis. He earned his Ph.D. in Analytical Chemistry from Peking University and completed postdoctoral work at MIT and UC Berkeley. His research focuses on mass spectrometry, metabolomics, and proteomics, with key projects including drug metabolism analysis, human neurogenesis studies, and advanced sample preparation techniques. Wang’s contributions have garnered several awards, such as the Shanghai Pujiang Talent Plan Award and recognition at MIT. His expertise in analytical techniques and innovative methods has significantly impacted both academic research and industry practices.

Professional Profiles:

Education

Xin Wang completed his B.Sc. in Chemistry at Wuhan University, China, in 2010. He pursued his Ph.D. in Analytical Chemistry at Peking University, graduating in 2015. Following his doctoral studies, Dr. Wang undertook postdoctoral research at the Massachusetts Institute of Technology (MIT) from 2015 to 2018. Since 2020, he has been serving as a Tenure-Track Associate Professor at the School of Pharmaceutical Sciences, Shanghai Jiao Tong University, China.

Professional Experience

Xin Wang’s professional experience includes a significant role as a Tenure-Track Associate Professor at the School of Pharmaceutical Sciences, Shanghai Jiao Tong University, where he has been since 2020. Before this, he was a Senior Postdoctoral Associate at MIT’s Department of Biological Engineering from 2018 to 2019, and a Postdoctoral Associate in the same department from 2015 to 2018. His earlier academic journey includes a Ph.D. in Analytical Chemistry from Peking University, where he also worked as a Visiting Graduate Student at UC Berkeley.

Research Interest

Xin Wang’s research interests are at the forefront of pharmaceutical and biomedical analysis, emphasizing the use of advanced analytical techniques. His work primarily focuses on mass spectrometry and its applications in drug metabolism and toxicity testing, aiming to replace traditional trials with in vitro human systems. He is also deeply engaged in metabolomics and proteomics, using these techniques to unravel metabolic features in human neurogenesis and other physiological processes. Wang has developed innovative methods in solid-phase microextraction to enhance the sensitivity and accuracy of analyzing low-molecular-mass compounds. His research integrates these areas to advance understanding in drug testing, biomarker discovery, and the mechanistic insights into human health and disease. This multidisciplinary approach not only pushes the boundaries of analytical chemistry but also contributes to more effective and efficient drug development and disease treatment strategies.

Award and Honors

Xin Wang has received several prestigious awards and honors throughout his career. In 2023, he was recognized as an Outstanding Individual with Exceptional Contributions in Education by the School of Pharmacy at Shanghai Jiao Tong University. He also won the Second Prize in the Young Professor Teaching Skills Competition at Shanghai Jiao Tong University in 2022. Wang’s accolades include the Shanghai Overseas High-Level Talent Program Award and the Shanghai Pujiang Talent Plan Award, both in 2020. In 2016, he earned First Place in the MIT Center for Environmental Health Sciences Session. Additionally, he was awarded the First Prize in the Science and Technology Award from the China Association for Instrumental Analysis in 2015. Earlier achievements include the Aoqing Tang Scholarship (2015), the Brilliance Scholarship (2014), and multiple awards for his graduate research and innovation.

Research Skills

Xin Wang possesses advanced research skills in several key areas of analytical and biomedical science. His expertise includes pharmaceutical and biomedical analysis, utilizing techniques such as mass spectrometry, metabolomics, and proteomics to study complex biological systems. He is proficient in solid-phase microextraction and has developed innovative methods for capturing and quantifying low-molecular-mass compounds. Wang’s work with time-dependent metabolomics and LC-MS-based quantitation reflects his ability to apply cutting-edge analytical techniques to understand human neurogenesis and drug metabolism. His research in automated sample preparation and ambient mass spectrometry demonstrates his skills in developing novel methodologies for high-sensitivity detection and analysis. Wang’s contributions to bioanalytical strategies and experimental design have been recognized and published in top scientific journals, showcasing his ability to push the boundaries of current research methodologies.

Publications

  1. “Mass spectrometry‐based metabolomics for the investigation of antibiotic–bacterial interactions”
    • Authors: Xin Wang
    • Year: 2024
  2. “A new approach towards highly sensitive detection of endogenous N-acetylaspartic acid, N-acetylglutamic acid, and N-acetylaspartylglutamic acid in brain tissues based on strong anion exchange monolith microextraction coupled with UHPLC-MS/MS”
    • Authors: Xin Wang
    • Year: 2024
  3. “Mass spectrometry-based quantitation combined with time-dependent metabolomics to discover metabolic features in human neurogenesis using neural constructs generated from neural progenitor cells”
    • Authors: Xin Wang
    • Year: 2023
  4. “Mass spectrometry analysis of S-nitrosylation of proteins and its role in cancer, cardiovascular and neurodegenerative diseases”
    • Authors: Xin Wang
    • Year: 2022
  5. “Low Doses of Arsenic in a Mouse Model of Human Exposure and in Neuronal Culture Lead to S-Nitrosylation of Synaptic Proteins and Apoptosis via Nitric Oxide”
    • Authors: Xin Wang
    • Year: 2020
  6. “Analysis of an Integrated Human Multiorgan Microphysiological System for Combined Tolcapone Metabolism and Brain Metabolomics”
    • Authors: Xin Wang
    • Year: 2019
  7. “Automated Online Solid-Phase Derivatization for Sensitive Quantification of Endogenous S-Nitrosoglutathione and Rapid Capture of Other Low-Molecular-Mass S-Nitrosothiols”
    • Authors: Xin Wang
    • Year: 2018
  8. “Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function”
    • Authors: Xin Wang
    • Year: 2018
  9. “Fast analysis of glycosides based on HKUST-1-coated monolith solid-phase microextraction and direct analysis in real-time mass spectrometry”
    • Authors: Xin Wang
    • Year: 2017
  10. “Polymer‐based monolithic column with incorporated chiral metal–organic framework for enantioseparation of methyl phenyl sulfoxide using nano‐liquid chromatography”
    • Authors: Xin Wang
    • Year: 2016